Philip E. Lammers
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Lung Cancer Research Studies
-
- Biosimilars and Bioanalytical Methods
Papers in
- Oncology 21
- Lung Cancer Research Studies 5
- CAR-T cell therapy research 4
- HER2/EGFR in Cancer Research 4
- Colorectal Cancer Treatments and Studies 3
-
- Lung Cancer Treatments and Mutations 7
- Co-authors
- Ira Jacobs (7 shared papers)Carmen Criscitiello (2 shared papers)Giuseppe Curigliano (2 shared papers)Gladys N. Nangami (3 shared papers)Josiah Ochieng (3 shared papers)Amos M. Sakwe (3 shared papers)Christian Jackisch (1 shared paper)Leora Horn (3 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Journal of Thoracic Oncology (4 papers)Pharmaceuticals (2 papers)Cancer Medicine (2 papers)Cancer Research (2 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Philip E. Lammers
41 papers receiving 767 citations
Peers
Comparison fields: 5 of 89
- Oncology 303
- Immunology 144
- Cancer Research 82
- Radiology, Nuclear Medicine and Imaging 93
- Pulmonary and Respiratory Medicine 110
Countries citing papers authored by Philip E. Lammers
This map shows the geographic impact of Philip E. Lammers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip E. Lammers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip E. Lammers more than expected).
Fields of papers citing papers by Philip E. Lammers
This network shows the impact of papers produced by Philip E. Lammers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip E. Lammers. The network helps show where Philip E. Lammers may publish in the future.
Co-authors
The 25 scholars most cited alongside Philip E. Lammers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 79 | |
| 2 | 2019 | 58 | |
| 3 | 2018 | 48 | |
| 4 | 2018 | 46 | |
| 5 | 2016 | 44 | |
| 6 | 2015 | 39 | |
| 7 | 2015 | 37 | |
| 8 | 2021 | 37 | |
| 9 | 2017 | 37 | |
| 10 | 2017 | 35 | |
| 11 | 2013 | 31 | |
| 12 | 2018 | 28 | |
| 13 | 2018 | 27 | |
| 14 | 2020 | 27 | |
| 15 | 2016 | 22 | |
| 16 | 2016 | 22 | |
| 17 | 2014 | 20 | |
| 18 | 2016 | 20 | |
| 19 | 2015 | 17 | |
| 20 | 2005 | 14 |
About Philip E. Lammers
Philip E. Lammers is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Cancer Research and Molecular Biology, having authored 42 papers that have together received 780 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Lung Cancer Research Studies (5 papers), Biosimilars and Bioanalytical Methods (5 papers), Cancer Genomics and Diagnostics (4 papers), CAR-T cell therapy research (4 papers), HER2/EGFR in Cancer Research (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Oncology (303 citations), Immunology (144 citations), Cancer Research (82 citations), Radiology, Nuclear Medicine and Imaging (93 citations) and Pulmonary and Respiratory Medicine (110 citations). Philip E. Lammers has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Ira Jacobs, Carmen Criscitiello, Giuseppe Curigliano, Gladys N. Nangami, Josiah Ochieng, Amos M. Sakwe, Christian Jackisch, Leora Horn, Thomas H. Cartwright and Bradley J. Monk. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Pharmaceuticals, Cancer Medicine and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.